- Home
- FATE vs ECBK Comparison
FATE vs ECBK Comparison
Compare FATE & ECBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FATE | ECBK |
|---|---|---|
| Founded | 2007 | 1919 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.6M | 153.1M |
| IPO Year | 2013 | 2022 |
Fundamental Metrics
Financial Performance| Metric | FATE | ECBK |
|---|---|---|
| Price | $1.46 | $17.95 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $3.92 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 6.3K |
| Earning Date | 01-01-0001 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.62 |
| Revenue | ★ $13,631,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $28.66 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.66 | $14.55 |
| 52 Week High | $1.94 | $20.05 |
Technical Indicators
Market Signals| Indicator | FATE | ECBK |
|---|---|---|
| Relative Strength Index (RSI) | 60.98 | 53.55 |
| Support Level | $1.31 | $17.80 |
| Resistance Level | $1.40 | $20.05 |
| Average True Range (ATR) | 0.09 | 0.45 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 84.72 | 11.42 |
Price Performance
Historical ComparisonAbout FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About ECBK ECB Bancorp Inc.
ECB Bancorp Inc operates as a bank holding company of Everett Co-operative Bank. The firm through its subsidiary engages in business consisting of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential real estate loans, commercial real estate, and multifamily real estate loans, construction and land loans and home equity lines of credit.